These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 23837451)

  • 1. CD44 as a molecular marker to screen cancer stem cells in hypopharyngeal cancer.
    Shen C; Xiang M; Nie C; Hu H; Ma Y; Wu H
    Acta Otolaryngol; 2013 Nov; 133(11):1219-26. PubMed ID: 23837451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells.
    Patrawala L; Calhoun-Davis T; Schneider-Broussard R; Tang DG
    Cancer Res; 2007 Jul; 67(14):6796-805. PubMed ID: 17638891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas.
    Adams A; Warner K; Pearson AT; Zhang Z; Kim HS; Mochizuki D; Basura G; Helman J; Mantesso A; Castilho RM; Wicha MS; Nör JE
    Oncotarget; 2015 Sep; 6(29):26633-50. PubMed ID: 26449187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral heterogeneity in the self-renewal and tumorigenic differentiation of ovarian cancer.
    Abelson S; Shamai Y; Berger L; Shouval R; Skorecki K; Tzukerman M
    Stem Cells; 2012 Mar; 30(3):415-24. PubMed ID: 22267284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production.
    Hiraga T; Ito S; Nakamura H
    Cancer Res; 2013 Jul; 73(13):4112-22. PubMed ID: 23633482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
    Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
    Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enriched CD44(+)/CD24(-) population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC).
    Ma F; Li H; Wang H; Shi X; Fan Y; Ding X; Lin C; Zhan Q; Qian H; Xu B
    Cancer Lett; 2014 Oct; 353(2):153-9. PubMed ID: 25130168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and identification of a distinct side population cancer cells in the human epidermal squamous cancer cell line A431.
    Geng S; Wang Q; Wang J; Hu Z; Liu C; Qiu J; Zeng W
    Arch Dermatol Res; 2011 Apr; 303(3):181-9. PubMed ID: 21240514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semi-quantitative evaluation of CD44(+) /CD24(-) tumor cell distribution in breast cancer tissue using a newly developed fluorescence immunohistochemical staining method.
    Kai M; Onishi H; Souzaki M; Tanaka H; Kubo M; Tanaka M; Katano M
    Cancer Sci; 2011 Dec; 102(12):2132-8. PubMed ID: 21838786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of stem-like cells from spontaneous feline mammary carcinomas: phenotypic characterization and tumorigenic potential.
    Barbieri F; Wurth R; Ratto A; Campanella C; Vito G; Thellung S; Daga A; Cilli M; Ferrari A; Florio T
    Exp Cell Res; 2012 Apr; 318(7):847-60. PubMed ID: 22366263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.
    Pries R; Witrkopf N; Trenkle T; Nitsch SM; Wollenberg B
    In Vivo; 2008; 22(1):89-92. PubMed ID: 18396788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentivirus-mediated RNA interference inhibits the tumorigenicity of cluster of differentiation 44
    Shen C; Ye B; Hu H; Nie C; Ma Y; Lv J; Wu H; Xiang M
    Oncol Lett; 2017 Nov; 14(5):5354-5360. PubMed ID: 29113169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SSEA-3 as a novel amplifying cancer cell surface marker in colorectal cancers.
    Suzuki Y; Haraguchi N; Takahashi H; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Ishii H; Doki Y; Mori M; Yamamoto H
    Int J Oncol; 2013 Jan; 42(1):161-7. PubMed ID: 23175153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldehyde dehydrogenase activity in cancer stem cells from canine mammary carcinoma cell lines.
    Michishita M; Akiyoshi R; Suemizu H; Nakagawa T; Sasaki N; Takemitsu H; Arai T; Takahashi K
    Vet J; 2012 Aug; 193(2):508-13. PubMed ID: 22326935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of CD44 and CD24 markers discriminates the epitheliod from the fibroblastoid subset in a sarcomatoid renal carcinoma cell line: evidence suggesting the existence of cancer stem cells in both subsets as studied with sorted cells.
    Hsieh CH; Hsiung SC; Yeh CT; Yen CF; Chou YW; Lei WY; Pang ST; Chuang CK; Liao SK
    Oncotarget; 2017 Feb; 8(9):15593-15609. PubMed ID: 28121626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of cancer stem cells in human prostate cancer cells.
    Lee EK; Cho H; Kim CW
    Biochem Biophys Res Commun; 2011 Aug; 412(2):279-85. PubMed ID: 21820414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment.
    Kinugasa Y; Matsui T; Takakura N
    Stem Cells; 2014 Jan; 32(1):145-56. PubMed ID: 24395741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.
    Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N
    J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
    Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
    J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44v8-10 is a cancer-specific marker for gastric cancer stem cells.
    Lau WM; Teng E; Chong HS; Lopez KA; Tay AY; Salto-Tellez M; Shabbir A; So JB; Chan SL
    Cancer Res; 2014 May; 74(9):2630-41. PubMed ID: 24618343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.